Pharmaceutical Product Development Inc. (Nasdaq:PPDI) announced that its board of directors has named Raymond H. Hill as PPD's new chief executive officer and elected him to the board of directors, both effective September 16. Mr. Hill comes to PPD after eight years with IMS Health, Inc., a provider of data, market research and consulting services to clients in the pharmaceutical and health care industries. He most recently served as president of IMS Consulting Group. During his tenure at IMS, he oversaw a strategy of aggressive organic and acquisition-based growth. Annual revenue increased five-fold over seven years helping to transform IMS from its data and market research roots and make it a leader in pharmaceuticals consulting. He also served on the executive leadership team of IMS, helping to set the overall direction of the company.

Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery, development, and lifecycle management services. It operates in two segments, Clinical Development Services and Laboratory Services.

Read the full article and the disclaimer at : http://doubleinstocks.com/?p=18588